AstraZeneca's new TV ad for Farxiga focuses on chronic kidney disease indication

January 31, 2022 02:24 PM EST

AstraZeneca adds chronic kidney disease TV ad to Farxiga portfolio

Beth Snyder Bulik

Senior Editor

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

ENDPOINTS CAREERS

VP, Clinical Development / CMO / CDO‬ ‭ (Stealth Portfolio Company)

Autonomy Bio Inc.

San Francisco, CA 94107, USA

view job offer post your job now

TRENDING NOW

Updated: Patient dies in Rocket gene therapy trial, which is put on clinical hold by FDA

Lilly to buy non-opioid pain biotech SiteOne for up to $1B

RFK Jr. ends annual Covid vaccine recommendations for kids, pregnant women

Investors pump $130M into protein degrader startup GlycoEra

Biogen taps City Therapeutics in RNAi deal worth up to $1B

sponsored

From weeks to days: how Aizon Intelligent Agents transform pharma validation